|
|
|
|
|
|
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期- |
A Phase II, Randomised, Double-blind, Placebo-controlled Clinical Trial to Assess the Safety and Efficacy of AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19
The ARCADIA Trial is a randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with either Type 1 or Type 2 diabetes, hospitalised with COVID-19.
100 项与 St George Street Capital Ltd. 相关的临床结果
0 项与 St George Street Capital Ltd. 相关的专利(医药)
100 项与 St George Street Capital Ltd. 相关的药物交易
100 项与 St George Street Capital Ltd. 相关的转化医学